ROCÍO
ALLER DE LA FUENTE
PROFESORES TITULARES DE UNIVERSIDAD
![Foto de ROCÍO](/img/nophoto.png)
![Foto de Hospital Universitario Virgen del Rocío](/img/noimage_org.png)
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (27)
2024
-
Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: results of a Delphi study
Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 337-346
-
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
United European Gastroenterology Journal
-
One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population
United European Gastroenterology Journal
-
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia
-
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
Gut, Vol. 73, Núm. 5, pp. 825-834
-
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
Hepatology, Vol. 79, Núm. 1, pp. 135-148
-
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Journal of Gastroenterology, Vol. 59, Núm. 7, pp. 586-597
2023
-
AEEH «Consensus about detection and referral of hidden prevalent liver diseases»
Gastroenterologia y Hepatologia, Vol. 46, Núm. 3, pp. 236-247
-
Liver investigation: Testing marker utility in steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol
Contemporary Clinical Trials, Vol. 134
-
Predicting liver-related events in NAFLD: A predictive model
Hepatology (Baltimore, Md.), Vol. 78, Núm. 4, pp. 1240-1251
-
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD
Liver International, Vol. 43, Núm. 9, pp. 1909-1919
2022
-
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach?
Gut, Vol. 71, Núm. 2, pp. 382-390
-
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
Scientific Reports, Vol. 12, Núm. 1
-
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
Liver International, Vol. 42, Núm. 8, pp. 1783-1792
2021
-
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease
EBioMedicine, Vol. 70
-
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Liver International, Vol. 41, Núm. 9, pp. 2076-2086
-
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
Journal of Hepatology, Vol. 75, Núm. 4, pp. 786-794
-
Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus
Advanced Science, Vol. 8, Núm. 11
2020
-
Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 1, pp. 216-225.e5
-
Dietary Approach to NAFLD
Non-Alcoholic Fatty Liver Disease: A 360-degree Overview (Springer International Publishing), pp. 271-287